Pfizer vaccine has adverse effects on US health worker

Allergic reactions were similar to two British health workers, causing the government there to tell people not to get the bullet if they had a history of severe allergies.

A health worker in Alaska suffered a severe allergic reaction after receiving the COfID-19 Pfizer-BioNTech vaccine and is now in the hospital but stable, a report said Wednesday.

The New York Times reported that the man received their bullet Tuesday, and Pfizer confirmed he was working with local authorities to investigate the incident.

Allergic reactions were similar to two health workers in Britain, causing the government there to tell people not to get the bullet if they had a history of severe allergies.

The U.S. regulator issued an emergency agreement with the warning that people who were familiar with allergies to ingredients within the vaccine should avoid it.

“We do not have all the details of the report from Alaska of a possible adverse allergic reaction but we are actively working with local health authorities to evaluate,” a Pfizer spokesperson said. .

“We will monitor closely all reports of adverse allergic reactions following immunization and update billing language if necessary.”

Volunteers for a Pfizer clinical trial of 44,000 people were banned if they had a history of allergic reactions to vaccines or components of the COVID-19 vaccine.

Overall, the trial found no adverse safety issues, but regulators and the company continue to monitor for adverse events after receiving the vaccine.

The U.S. is vaccinating around three million people this week with the vaccine, and hopes to reach 20 million people this month if another vaccine, developed by Moderna, is approved.


Follow the latest news on coronavirus behavior (COVID-19)


© 2020 AFP

Citation: US health worker is adversely affected by Pfizer vaccine (2020, December 16) on December 17, 2020 retrieved from https://medicalxpress.com/news/2020-12-health-worker-allergic-reaction- pfizer.html

This document is subject to copyright. Other than any fair treatment for the purpose of scrutiny or private investigation, no part may be reproduced without written permission. The content is provided for informational purposes only.

Source